연구성과로 돌아가기
JCR 2024 저널 목록 (638 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Law & Social Inquiry | CAMBRIDGE UNIV PRESS | 0897-6546 | 1747-4469 | SSCI | LAW | 1,636 | 1.0 | Q2 | 32.4 | 67.6 | 141/434 | 1.5 | Q1 | 1.0 | 0.4 | 1.44 | 74/434 | Q1 | 83.06 | 0.002 | 0.390 | 0.693 | Q1 | 46 | 82.6% | 9.9 | 11.1 | 38 | 41.8% | 2025-08-05 16:03:42 | 바로가기 |
| MACROMOLECULAR BIOSCIENCE | WILEY-V C H VERLAG GMBH | 1616-5187 | 1616-5195 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 9,337 | 4.1 | Q2 | 32.4 | 67.6 | 104/319 | 4.6 | Q2 | 3.9 | 0.7 | 0.68 | 152/320 | Q2 | 52.66 | 0.006 | 1.229 | 0.695 | Q3 | 171 | 85.4% | 5.9 | 6.2 | 146 | 29.8% | 2025-08-05 16:02:32 | 바로가기 |
| MACROMOLECULAR BIOSCIENCE | WILEY-V C H VERLAG GMBH | 1616-5187 | 1616-5195 | SCIE | POLYMER SCIENCE | 9,337 | 4.1 | Q2 | 32.4 | 67.6 | 31/94 | 4.6 | Q1 | 3.9 | 0.7 | 0.68 | 31/94 | Q2 | 67.55 | 0.006 | 1.229 | 0.695 | Q1 | 171 | 85.4% | 5.9 | 6.2 | 146 | 29.8% | 2025-08-05 16:04:47 | 바로가기 |
| McGill Journal of Law and Health | MCGILL UNIV, FAC LAW | 1920-4825 | 1920-4825 | ESCI | LAW | 35 | 1.0 | Q2 | 32.4 | 67.6 | 141/434 | 0.5 | Q3 | 1.0 | <0.1 | 0.15 | 351/434 | Q4 | 19.24 | 0.000 | 0.010 | 0.238 | Q3 | 3 | 100.0% | N/A | 13.6 | 3 | 0.0% | 2025-08-05 16:03:45 | 바로가기 |
| MEDICAL ONCOLOGY | HUMANA PRESS INC | 1357-0560 | 1559-131X | SCIE | ONCOLOGY | 7,563 | 3.5 | Q2 | 32.4 | 67.6 | 106/326 | 3.3 | Q2 | 3.4 | 1.0 | 0.69 | 145/326 | Q2 | 55.67 | 0.005 | 1.159 | 0.672 | Q3 | 268 | 52.2% | 6.8 | 6.2 | 140 | 12.3% | 2025-08-05 16:04:24 | 바로가기 |
| Melbourne Journal of International Law | UNIV MELBOURNE, MELBOURNE LAW SCH | 1444-8602 | 1444-8610 | ESCI | LAW | 282 | 1.0 | Q2 | 32.4 | 67.6 | 141/434 | 1.2 | Q2 | 0.9 | 0.2 | 0.84 | 157/434 | Q2 | 63.94 | 0.000 | 0.073 | 0.609 | Q1 | 5 | 100.0% | 9.8 | 7.4 | 5 | 0.0% | 2025-08-05 16:03:43 | 바로가기 |
| Molecular Medicine Reports | SPANDIDOS PUBL LTD | 1791-2997 | 1791-3004 | SCIE | ONCOLOGY | 26,534 | 3.5 | Q2 | 32.4 | 67.6 | 106/326 | 3.2 | Q2 | 3.5 | 1.4 | 0.78 | 124/326 | Q2 | 62.12 | 0.016 | 3.515 | 0.606 | Q3 | 181 | 69.6% | 6.6 | 6.4 | 126 | 82.5% | 2025-08-05 16:04:24 | 바로가기 |
| Nanoscale Research Letters | SPRINGER | 1931-7573 | 1556-276X | SCIE | PHYSICS, APPLIED | 18,387 | 4.1 | Q2 | 32.4 | 67.6 | 61/187 | 5.5 | Q1 | 4.1 | N/A | 0.73 | 64/187 | Q2 | 66.04 | 0.006 | 1.366 | 0.860 | Q2 | 0 | N/A | 8.2 | N/A | 0 | 100.0% | 2025-08-05 16:04:38 | 바로가기 |
| OPTICS EXPRESS | Optica Publishing Group | 1094-4087 | N/A | SCIE | OPTICS | 143,376 | 3.3 | Q2 | 32.4 | 67.6 | 41/125 | 3.5 | Q2 | 2.9 | 0.8 | 1.03 | 32/125 | Q2 | 74.80 | 0.088 | 19.686 | 0.654 | Q2 | 3681 | 100.0% | 6.9 | 6.8 | 3680 | 99.7% | 2025-08-05 16:04:27 | 바로가기 |
| OPTICS LETTERS | Optica Publishing Group | 0146-9592 | 1539-4794 | SCIE | OPTICS | 76,109 | 3.3 | Q2 | 32.4 | 67.6 | 41/125 | 3.2 | Q2 | 3.0 | 1.0 | 1.04 | 31/125 | Q1 | 75.60 | 0.042 | 9.353 | 0.667 | Q2 | 1509 | 100.0% | 8.7 | 6.2 | 1509 | 2.1% | 2025-08-05 16:04:27 | 바로가기 |
| Oxford Journal of Legal Studies | OXFORD UNIV PRESS | 0143-6503 | 1464-3820 | SSCI | LAW | 1,300 | 1.0 | Q2 | 32.4 | 67.6 | 141/434 | 1.4 | Q1 | 0.9 | 0.3 | 1.45 | 73/434 | Q1 | 83.29 | 0.001 | 0.264 | 0.729 | Q1 | 45 | 88.9% | 13.1 | 13.2 | 40 | 56.5% | 2025-08-05 16:03:42 | 바로가기 |
| PLANT SCIENCE | ELSEVIER IRELAND LTD | 0168-9452 | 1873-2259 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 23,100 | 4.1 | Q2 | 32.4 | 67.6 | 104/319 | 5.1 | Q1 | 4.0 | 1.1 | 1.00 | 72/320 | Q1 | 77.66 | 0.011 | 2.427 | 0.879 | Q2 | 294 | 85.0% | 9.1 | 8.6 | 250 | 11.0% | 2025-08-05 16:02:32 | 바로가기 |
| Practical Radiation Oncology | ELSEVIER SCIENCE INC | 1879-8500 | 1879-8500 | SCIE | ONCOLOGY | 3,428 | 3.5 | Q2 | 32.4 | 67.6 | 106/326 | 3.1 | Q3 | 3.2 | 1.4 | 1.01 | 80/326 | Q1 | 75.61 | 0.005 | 1.010 | 1.003 | Q2 | 111 | 95.5% | 5.1 | 7.1 | 106 | 8.3% | 2025-08-05 16:04:24 | 바로가기 |
| PSYCHO-ONCOLOGY | WILEY | 1057-9249 | 1099-1611 | SCIE | ONCOLOGY | 14,455 | 3.5 | Q2 | 32.4 | 67.6 | 106/326 | 4.0 | Q2 | 3.3 | 0.6 | 0.90 | 97/326 | Q2 | 70.40 | 0.011 | 2.400 | 1.190 | Q2 | 151 | 79.5% | 7.9 | 7.5 | 120 | 44.2% | 2025-08-05 16:04:24 | 바로가기 |
| Saudi Dental Journal | SPRINGERNATURE | 1013-9052 | 1658-3558 | ESCI | DENTISTRY, ORAL SURGERY & MEDICINE | 2,070 | 2.3 | Q2 | 32.4 | 67.6 | 53/162 | 2.4 | Q2 | 2.2 | 0.4 | 0.79 | 76/162 | Q2 | 53.40 | 0.002 | 0.381 | 0.415 | Q3 | 255 | 76.9% | 4.4 | 8.1 | 196 | 98.8% | 2025-08-05 16:02:50 | 바로가기 |
페이지 이동: